Sartorius AG (0NIQ) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Sartorius Ag.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.276 Ladies and gentlemen, welcome to the Sartorius and Sartorius Stadium Biotech 00:00:05.276 -- 00:00:10.280 H1 2025 conference call and live webcast. I am Mathilde, the 00:00:10.280 -- 00:00:15.365 chorus call operator. I would like to remind you that all participants will be in 00:00:15.365 -- 00:00:19.188 listen-only mode and the conference is being recorded. 00:00:19.188 -- 00:00:24.192 This call is scheduled for 60 minutes. The presentation will be followed by a Q&A 00:00:24.192 -- 00:00:29.731 session. In order to give all participants the opportunity to ask a question, 00:00:29.731 -- 00:00:35.198 we ask that the number of questions per person be limited to two. 00:00:35.198 -- 00:00:39.023 In addition, and in the interest of all participants, 00:00:39.023 -- 00:00:43.468 questions with the same content will only be answered once. 00:00:43.468 -- 00:00:49.476 You can register for questions at any time by pressing star and one on your telephone. 00:00:49.476 -- 00:00:53.521 For operator assistance, please press star and zero. 00:00:53.521 -- 00:00:58.081 The conference must not be recorded for publication or broadcast. 00:00:58.081 -- 00:01:02.988 At this time, it's my pleasure to hand over to Michael Grothirk, CEO. 00:01:02.988 -- 00:01:05.408 Please go ahead. 00:01:05.711 -- 00:01:10.017 Thank you, Mathilde, and good afternoon, everyone, and thank you for joining today's 00:01:10.017 -- 00:01:15.084 call on our H1 results of the Sartorius AG, as well as Sartorius Data and 00:01:15.084 -- 00:01:20.391 Biotech. Today, I'm together with Florian Funk, our CFO 00:01:20.391 -- 00:01:26.026 with René Faber, our head of Bioprocessing Division and CEO of Sartorius Data and Biotech, 00:01:26.026 -- 00:01:31.234 and also Alexandra Gatzem...